China NMPA Product Recall - Femoral Components

DePuy Orthopaedics, Inc., a medical device manufacturer, initiated a voluntary Class III recall of specific femoral components used in artificial knee joints. This action was reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., with the recall announcement published on February 7, 2021. The central issue leading to the recall was the potential for the taper dimension of certain product models and batches to exceed established quality standards. This non-conformance raised concerns regarding the product's quality and performance. The regulatory oversight for this recall falls under the National Medical Products Administration (NMPA) in China. A Class III designation signifies that the use of, or exposure to, the affected product is not likely to cause adverse health consequences. The company's required action is to conduct a thorough voluntary recall, involving the identification and retrieval of all affected femoral components from the market. Further detailed information, including specific product models, specifications, and batch numbers, is available in the associated "Medical Device Recall Event Report Form" attached to the NMPA's public notice. This measure underscores a commitment to product quality and patient safety.